Evidence map›Paper›PMID 34665151›Full record

ArticleJournal of medical Internet research2021

Revealing the Nature of Chronic Obstructive Pulmonary Disease Using Self-tracking and Analysis of Contact Patterns: Longitudinal Study.

Klaus Phanareth, Astrid Laura Dam, Martin A B C Hansen, Signe Lindskrog, Søren Vingtoft, Lars Kayser

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06988566 (Telemedical Monitoring and Treatment of COPD Patients Associated With General Practice), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06988566 nacompletednot on this map

Telemedical Monitoring and Treatment of COPD Patients Associated With General Practice (TEMOKAP)

TypeinterventionalSponsorECM Klinikken APSRan2020 to 2022Enrolled184ConditionsCOPD (Chronic Obstructive Pulmonary Disease)ArmsIntervention Group
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Klaus PhanarethEpital Health, Gentofte, Denmark.ORCID 0000-0003-4010-7083
Astrid Laura DamDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2332-3262
Martin A B C HansenEpital Health, Gentofte, Denmark.ORCID 0000-0003-2140-3071
Signe LindskrogDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4662-7063
Søren VingtoftRegion Zealand, Sorø, Denmark.ORCID 0000-0002-6999-1573
Lars KayserDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-0909-4088
University of Copenhagen · DKGentofte Hospital · DKRegion Zealand · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is the fourth leading cause of death and is characterized by a progressive loss of pulmonary function over time with intermittent episodes of exacerbations. Rapid and proactive interventions may reduce the burden of the condition for the patients. Telehealth solutions involving self-tracking of vital parameters such as pulmonary function, oxygen saturation, heart rate, and temperature with synchronous communication of health data may become a powerful solution as they enable health care professionals to react with a proactive and adequate response. We have taken this idea to the next level in the Epital Care Model and organized a person-centered technology-assisted ecosystem to provide health services to COPD patients.

objectiveThe objective is to reveal the nature of COPD by combining technology with a person-centered design aimed to benefit from interactions based on patient-reported outcome data and to assess the needed kind of contacts to best treat exacerbations. We wanted to know the following: (1) What are the incidences of mild, moderate, and severe exacerbations in a mixed population of COPD patients? (2) What are the courses of mild, moderate, and severe exacerbations? And (3) How is the activity and pattern of contacts with health professionals related to the participant conditions?

methodsParticipants were recruited by convenience sampling from November 2013 to December 2015. The participants' sex, age, forced expiratory volume during the first second, pulse rate, and oxygen saturation were registered at entry. During the study, we registered number of days, number of exacerbations, and number of contact notes coded into care and treatment notes. Each participant was classified according to GOLD I-IV and risk factor group A-D. Participants reported their clinical status using a tablet by answering 4 questions and sending 3 semiautomated measurements.

resultsOf the 87 participants, 11 were in risk factor group A, 24 in B, 13 in C, and 39 in D. The number of observed days was 31,801 days with 12,470 measurements, 1397 care notes, and 1704 treatment notes. A total of 254 exacerbations were treated and only 18 caused hospitalization. Those in risk factor group D had the highest number of hospitalizations (16), exacerbations (151), and contacts (1910). The initial contacts during the first month declined within 3 months to one-third for care contacts and one-half for treatment contacts and reached a plateau after 4 months.

conclusionsThe majority of COPD patients in risk factor group D can be managed virtually, and only 13% of those with severe exacerbations required hospitalization. Contact to the health care professionals decreases markedly within the first months after enrollment. These results provide a new and detailed insight into the course of COPD. We propose a resilience index for virtual clinical management making it easier to compare results across settings.

Indexed as

EcosystemPulmonary Disease, Chronic ObstructiveDisease ProgressionHumansLongitudinal StudiesQuality of LifeCOPDearly interventionsEpital Care Modelexacerbationspatient-reported outcomes

Identifiers

PMID34665151
PMCPMC8564654
OpenAlexW3187544458

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.